Date
20 May 2019
Trade War With China Threatens To Make Problems With Generic Medicine Worse
In Forbes, Judy Stone assesses the effect of the USA–China trade war on the supply of generic medicines. She quotes Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, on how the trade war will raise the risk of antibiotic shortages still further. Her piece covers the complexity of the antibiotic manufacturing chain and its reliance on companies based in China.
Direct links
"A trade war will further jeopardize the supply of antibiotics… It will cause delays and shortages in a health system that is already stressed with pressures on pricing, value of pharmaceuticals and severe shortages in basic essential medicines. Jayasree K Iyer, Executive Director, Access to Medecine Foundation